sarcoma
Conditions
Interventions
Sponsors
National Institutes for Quantum Science and Technology (QST)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Sarcoma cases treated with Carbon-ion raditoherpy therapy from April 1997 to July 2025.
Exclusion criteria
Exclusion criteria: Patients who have requested that their data not be used for the purpose of disclosing information about this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local control, progression-free survival, overall survival | — |
Countries
Japan
Contacts
Public ContactHiroaki Ikawa
National Institutes for Quantum Science and Technology (QST) QST Hospital
Outcome results
None listed